BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 66272)

  • 1. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
    Forman J; Vitetta ES; Hart DA; Klein J
    J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid.
    Vitetta ES; Hart DA; Forman J
    J Immunol; 1978 Sep; 121(3):997-1001. PubMed ID: 690447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay.
    Forman J; Vitetta ES; Hart DA
    J Immunol; 1977 Mar; 118(3):803-8. PubMed ID: 66273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
    Forman J
    J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants.
    Fujiwara H; Tsuchida T; Levy RB; Shearer GM
    J Immunol; 1982 Sep; 129(3):1189-93. PubMed ID: 6179996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
    Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
    J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
    Henkart PA; Schmitt-Verhulst M; Shearer GM
    J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. IV. Correlation between the loss of cell surface trinitrophenyl-H-2 molecules and functional activity of derivatized cells in an anti-TNP-CML assay.
    Forman J; Vitetta ES
    J Immunol; 1978 Sep; 121(3):1002-6. PubMed ID: 80421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
    Arora PK; Hanna EE
    Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens.
    Teh HS; Teh SJ
    J Immunol; 1980 Nov; 125(5):1977-86. PubMed ID: 6159396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
    Handa K; Herrmann S
    J Immunol; 1985 Sep; 135(3):1564-72. PubMed ID: 2410495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
    Burakoff SJ; Germain RN; Benacerraf B
    J Exp Med; 1976 Dec; 144(6):1609-20. PubMed ID: 1087327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.
    Schmitt-Verhulst AM; Pettinelli CB; Henkart PA; Lunney JK; Shearer GM
    J Exp Med; 1978 Feb; 147(2):352-68. PubMed ID: 75237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens.
    Shaw S; Nelson DL; Shearer GM
    J Immunol; 1978 Jul; 121(1):281-9. PubMed ID: 78943
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature of the antigenic complex recognized by T lymphocytes. VIII. Specific inhibition of the stimulatory capacity of antigen-pulsed hapten-modified peritoneal exudate cells by anti-hapten antibody.
    Shevach EM; Chan C; Clement LT
    Eur J Immunol; 1982 Oct; 12(10):819-24. PubMed ID: 6184235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells.
    Finberg R; Greene MI; Benacerraf B; Burakoff SJ
    J Immunol; 1979 Sep; 123(3):1205-9. PubMed ID: 89164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split unresponsiveness to the trinitrophenyl determinant. I. Manoeuvers which suppress either humoral or cell-mediated immune responses.
    Ptak W; Rózycka D
    Eur J Immunol; 1977 Dec; 7(12):855-60. PubMed ID: 75801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of both I-A and I-E/C subregion antigens on accessory cells required for in vitro generation of cytotoxic T lymphocytes against alloantigens or TNBS-modified syngeneic cells.
    Pettinelli CB; Ahmann GB; Shearer GM
    J Immunol; 1980 Apr; 124(4):1911-6. PubMed ID: 6154084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.